C-reactive protein across the menstrual cycle

American Journal of Physical Anthropology

Volumn 136, Issue 2, 2008, Pages 138-146

  Wander, Katherine ^a   Brindle, Eleanor ^a   O'Connor, Kathleen A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biomarker; Estrogen; Inflammation; Progesterone

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; ESTRONE; FOLLITROPIN BETA SUBUNIT; PREGNANEDIOL; PROGESTERONE;

ADULT; ARTICLE; FEMALE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; OVULATION;

ADULT; AGING; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFECTION; INFLAMMATION; MENSTRUAL CYCLE; MIDDLE AGED; PREGNANEDIOL; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 44349145952     PISSN: 00029483     EISSN: 10968644     Source Type: Journal    
DOI: 10.1002/ajpa.20785     Document Type: Article

References (72)

1. Albert MA, Danielson E, Rifai N, Ridker PM. 2001. Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA 286:64-70.
2. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahi SM, Ferguson MWJ. 1999. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 155:1137-1146.
3. Austin MA, Zhang C, Humphries SE, Chandler WL, Talmud PJ, Edwards KL, Leonetti DL, Mcneely MJ, Fujimoto WY. 2004. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 68:179-188.
4. Beall CM, Decker MJ, Brittenham GM, Kushner I, Gebremedhin A, Strohl KP. 2002. An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci USA 99:17215-17218.
5. Blum CA, Müller B, Huber P, Kraenzlin M, Schindler C, De Geyter C, Keller U, Puder JJ. 2005. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 90:3230-3235.
6. Bouman A, Heineman MJ, Faas MM. 2005. Sex hormones and the immune response in humans. Hum Reprod Update 11:411-425.
7. Brindle E, Miller RC, Shofer JB, Klein NA, Soules MR, O'Connor KA. 2006. Urinary beta-luteinizing hormone and beta-follicle stimulating hormone immunoenzymometric assays for population research. Clin Biochem 39:1071-1079.
8. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, Sharma P, Lowe GDO, World MJ, Humphries SE, Hingorani AD. 2003. Human CRP gene polymorphism influences CRP levels. Arterioscler Thromb Vasc Biol 23:2063-2069.
9. Bukulmez O, Arici A. 2000. Leukocytes in ovarian function. Hum Reprod Update 6:1-15.
10. Calabrese EJ. 2001. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol 31:503-515.
11. Chenillot O, Henny J, Steinmetz J, Herbeth B, Wagner C, Siest G. 2000. High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med 38:1003-1011.
12. Critchley HOD, Kelly RW, Brenner RM, Baird DT. 2001. The endocrinology of menstruation-a role for the immune system. Clin Endocrinol 55:701-710.
13. Cushman M, Mailahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy RP. 1999. Hormone replacement therapy, inflammation and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 19:893-899.
14. Dandona P, Aljada A, Bandyopadhyay A. 2004. Inflammation: the link between insulin resistance, obesity, and diabetes. Trends Immunol 25:4-7.
15. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 321:199-204.
16. Decensi A, Omodei U, Robertson C, Bonanni B, Guerrieri-gonzaga A, Ramazzotto F, Johansson H, Mora S, Sandri MT, Cazzaniga M, Franchi M, Pecorelli S. 2002. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation 106:1224-1228.
17. Dreon DM, Slavin JL, Phinney SD. 2002. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 73:1245-1252.
18. Espey LL. 1980. Ovulation as an inflammatory reaction-a hypothesis. Biol Reprod 22:73-106.
19. Ford ES. 2003. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 108:1053-1058.
20. Ford ES, Giles WH, Myers GL, Rifal N, Ridker PM, Mannino DM. 2003. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 49:1353-1357.
21. Forouhi NG, Sattar N, McKeigue PM. 2001. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes 25:1327-1331.
22. Fröhlich M, Sund M, Thorand B, Hutchinson WL, Pepys MB, Koenig W. 2002. Lack of seasonal variation in C-reactive protein. Clin Chem 48:575-577.
23. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC. 1992. 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
24. Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C. 2006. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Maturitas 53:252-259.
25. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. 1999. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793-798.
26. Jilma B, Dirnberger E, Löscher I, Rumplmayr A, Hildebrandt J, Eichler H, Kapiotis S, Wagner OF. 1997. Menstrual cycleassociated changes in blood levels of interleukin-6, α 1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 130:69-75.
27. Kelly RW. 1994. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endo Rev 15:684-706.
28. Kluft C, de Maat MPM. 2001. Determination of the habitual low blood level of C-reactive protein in individuals. Ital Heart J 2:172-180.
29. Kluft C, Gevers Leuven JA, Heimerhorst FM, Krans HMJ. 2002. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormones replacement treatment. Vascul Pharmacol 39:149-154.
30. Kovacs A, Henriksson P, Hamsten A, Wallén H, Björkegren J, Tornvall P. 2005. Hormonal regulation of circulating C-reactive protein in men. Clin Chem 51:911-913.
31. LaMonte MJ, Durstine JL, Yanowitz FG, Lim T, DuBose KD, Davis P, Ainsworth BE. 2002. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation 106:403-406.
32. Libby P, Ridker PM, Maseri M. 2002. Inflammation and atherosclerosis. Circulation 105:1135-1143.
33. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB. 2004. Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50:130-134.
34. Macy EM, Hayes TE, Tracy RP. 1997. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52-58.
35. McDade TW, Burhop J, Dohnal J. 2004. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem 50:652-654.
36. McDade TW, Leonard WR, Burhop J, Reyes-Garcia V, Vadez V, Huanca T, Godoy RA. 2005. Predictors of C-reactive protein in Tsimane' 2 to 15 year-olds in lowland Bolivia. Am J Phys Anthropol 128:906-913.
37. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47:426-430.
38. Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, Soules MR, O'Connor KA. 2004. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin Chem 50:924-932.
39. Miro F, Aspinall LJ. 2005. The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Human Reprod 20:96-100.
40. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. 1999. Estrogen protects against cellular infiltration by reducing the expression of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 163:374-379.
41. Núñez-de la Mora A, Chatterton RT, Choudhury OA, Napolitano DA, Bentley GR. 2007. Childhood conditions influence adult progesterone levels. PLoS Med 4:e167.
42. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. 2001. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444-450.
43. O'Connor KA, Brindle E, Holman DJ, Klein NA, Soules MR, Campbell KL, Kohen F, Munro CJ, Shofer JB, Lasley BL, Wood JW. 2003. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 49:1139-1148.
44. O'Connor KA, Brindle E, Shofer JB, Miller RC, Klein NA, Soules MR, Campbell KL, Mar C, Handcock MS. 2004. Statistical correction for non-parallelism is a urinary enzyme immunoassay. J Immunoassay Immunochem 25:259-278.
45. O'Connor KA, Brindle E, Miller RC, Shofer JB, Ferrell RJ, Klein NA, Soules MR, Holman DJ, Mansfield PK, Wood JW. 2006. Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. Hum Reprod 21:1442-1452.
46. Panter-Brick C, Lunn PG, Baker R, Todd A. 2001. Elevated acute-phase protein in stunted Nepali children reporting low morbidity: different rural and urban profiles. Br J Nutr 85:125-131.
47. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith Jr SC, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511.
48. Pepys MB, Hirschfield GM. 2003. C-reactive protein: a critical update. J Clin Invest 111:1805-1812.
49. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. 2001. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334.
50. Prestwood KM, Unson C, Kulldorff M, Cushman M. 2004. The effect of different doses of micronized 17β-estradiol on C-reactive protein, interleukin-6, and lipids in older women. J Gerontol 59:827-832.
51. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. 1999. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100:713-716.
52. Roberts CW, Walker W, Alexander J. 2001. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 14:476-488.
53. Rogers A, Eastell R. 2001. The effect of 17β-estradiol on production of cytokines in cultures of peripheral blood. Bone 29:30-34.
54. Ropponen A, Aittomäki K, Tikkanen MJ, Ylikorkala O. 2005. Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. J Clin Endocrinol Metab 90:142-146.
55. Ross R. 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126.
56. Sacks GP, Seyani L, Lavery S, Trew G. 2004. Maternal C-reactive protein levels are raised at 4 weeks gestation. Human Reprod 19:1025-1030.
57. Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Smith GD, Watt G. 2004. Inverese association between birth weight and C-reactive protein concentrations in the MID-SPAN Family Study. Arterioscler Thromb Vasc Biol 24:583-587.
58. Schwartz NB. 1974. The role of FSH and LH and of their antibodies on follicle growth and on ovulation. Biol Reprod 10:236-272.
59. Shell-Duncan B, McDade T. 2004. Use of combined measures from capillary blood to assess iron deficiency in rural Kenyan children. J Nutr 134:384-387.
60. Sierksma A, van der Gaag MS, Kluft C, Hendriks HFJ. 2002. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 56:1130-1136.
61. Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J. 2002. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obstet Gynecol 186:969-977.
62. Sorensen MV, Leonard WR, Tarskaya LA, Ivanov KI, Snodgrass JJ, Alekseev VP, Krivoshapkin VG, Rifai N. 2006. High-sensitivity C-reactive protein, adiposity, and blood pressure in the Yakut of Siberia. Am J Hum Biol 18:766-775.
63. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. 2002. Weight loss reduced C-reactive protein levels in obese postmenopausal women. Circulation 105:564-569.
64. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Cianaand P, Maggi A. 2001. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21:1809-1818.
65. Vigushin DM, Pepys MB, Hawkins PN. 1993. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91:1351-1357.
66. Visser M, Bouter LM, McQuillen GM, Wener MH, Harris TB. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135.
67. Walsh BW, Paul S, Wild RA, Dean RA, Tracy RP, Cox DA, Anderson PW. 2000. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 85:214-218.
68. Watts DH, Krohn MA, Wener MH, Eschenbach DA. 1991. C-reactive protein in normal pregnancy. Obstet Gynecol 77:176-180.
69. Wener MH, Daum PR, McQuillan GM. 2000. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27:2351-2359.
70. Woodward M, Rumley A, Lowe GDO, Tunstall-Pedoe H. 2003. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 122:135-141.
71. Wu T, Mendola P, Buck GM. 2002. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 110:752-757.
72. Zitzmann M, Erran M, Kamischke A, Simoni M, Nieschlag E. 2005. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab 90:6603-6608.